Winner in the category "Emerging Startup"
Citrapeutics
'We’re honoured to receive this award. Just last year, we were attendees
at BioVaria 2024, inspired by the presentations and the energy!
We dreamed of presenting in 2025 — now we’re the winning team.
We owe this to the incredible support from our colleagues at the
Helmholtz Center for Infection Research, the Helmholtz Enterprise
program, and Ascenion.'
(Nikolas Chalkias and Frank Pessler)
Winner in the category "Rising Startup"
Green Elephant Biotech
'BioVaria offers exactly the stage that young biotech companies need:
close to science, practical, and in exchange with strong industrial partners.
We are delighted to receive this award. It confirms our belief that adherent
cell production needs to be not only more efficient, but also more scalable —
and that we are on the right track with our platform.'
(Joel Eichmann)
Emerging Startups 2025
Citrapeutics develops "first in class, first on target" compounds that inhibit a novel target in cancer, the enzyme cis-aconitate decarboxylase (ACOD1).
ENDOLEASE is the first implantable platform technology for super-selective intra-arterial drug delivery, boosting efficacy and minimizing side effects.
immuneAdvice pioneers the development of CD4-specific immune cell tracers (CD4 ICE-T) for non-invasive imaging, addressing the lack of early diagnostics for immune checkpoint inhibitor resistance.
Ovo Labs develops therapeutics that boost egg quality to solve the infertility crisis and turn every IVF attempt into a success story.
Unlocking the power of the immune system
Rising Startups 2025
Amyl Tx develops innovative biological therapies for the treatment of neurodegenerative diseases such as Alzheimer’s and Parkinson’s and of systemic amyloidosis.
At Green Elephant Biotech it is our vision to enable the production of life-saving medicines and vaccines through efficient cell cultivation using CO2-reduced materials.
HHC Medical is a health tech startup developing a platform technology for targeted and non-invasive drug delivery via wireless electroporation.
IRUBIS brings life-saving medications faster to patients by real-time monitoring in process development and drug manufacturing.
Phialogics is a preclinical biotech company specialized in engineering next-generation biologics to rebalance the immune response in acute and chronic inflammation.
BioVaria 2025 Press Release